PRECISELY ENGINEERING THE FUTURE OF OPHTHALMOLOGYTM

ABOUT ENVISIA THERAPEUTICS™

envisia1In 2013, Liquidia Technologies formed a new company, Envisia Therapeutics,™ to develop novel therapeutics that can address critical unmet needs in ophthalmology.

OPHTHALMOLOGY PROGRAMS

opthalmology2As many as 285 million people suffer from disease-related visual impairments and blindness, but an estimated 80 percent of these visual impairments are actually preventable.

THE PRINT® TECHNOLOGY

technology2The PRINT® technology is a proprietary system capable of engineering highly precise microparticle and nanoparticle systems.

ANNOUNCEMENTS

ENVISIA THERAPEUTICS ANNOUNCES APPOINTMENTS TO BOARD OF DIRECTORS

July 29th, 2014

Company Bolsters Board of Directors with Industry Thought Leaders  RESEARCH TRIANGLE PARK, NC – July 29, 2014 – Envisia Therapeutics today announced that it has made................READ MORE

ENVISIA THERAPEUTICS TO PRESENT NEW GLAUCOMA AND AMD DATA AT ARVO 2014

May 1st, 2014

Company to Make Eight Presentations at World’s Largest International Ophthalmology Conference RESEARCH TRIANGLE PARK, NC – May 1, 2014 – Envisia Therapeutics today announced that it................READ MORE

ENVISIA THERAPEUTICS TO PRESENT AT GTC BIO’s 6th ANNUAL OCULAR DISEASES & DRUG DISCOVERY CONFERENCE

March 20th, 2014

Company to Present New Data from its Drug Delivery Technology  RESEARCH TRIANGLE PARK, NC – March 20, 2014 – Envisia Therapeutics today announced that it will................READ MORE

Twitter

Copyright 2013 Envisia Therapeutics